Literature DB >> 6328528

Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection.

T H Lee, J E Coligan, T Homma, M F McLane, N Tachibana, M Essex.   

Abstract

Specific antibodies to cell membrane antigens found on human T-cell leukemia virus (HTLV)-infected cells have been detected in Japanese patients with adult T-cell leukemia/lymphoma and in asymptomatic carriers, using a live cell-membrane immunofluorescence assay. Reactivity of the positive antisera was analyzed using radioimmunoprecipitation and NaDodSO4/PAGE with the HTLV-infected tumor cell line Hut 102 (clone B2). The major cell-associated antigens identified include two glycoproteins of approximately equal to 61 and 45 kDa, which appear to be the most immunogenic species in exposed people, a nonglycosylated species of 42 kDa, and four additional species that contain gag gene-encoded antigens with sizes ranging from 19 to 55 kDa. The two glycoproteins ( gp61 and gp45 ) are encoded, at least in part, by the env gene of HTLV as evidenced by amino acid sequence analysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328528      PMCID: PMC345320          DOI: 10.1073/pnas.81.12.3856

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf-liver microsomes.

Authors:  J S Tkacz; O Lampen
Journal:  Biochem Biophys Res Commun       Date:  1975-07-08       Impact factor: 3.575

2.  Adult T-cell leukemia: clinical and hematologic features of 16 cases.

Authors:  T Uchiyama; J Yodoi; K Sagawa; K Takatsuki; H Uchino
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

3.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

4.  Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia.

Authors:  C C Huang; Y Hou; L K Woods; G E Moore; J Minowada
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

5.  Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas.

Authors:  A F Gazdar; D N Carney; P A Bunn; E K Russell; E S Jaffe; G P Schechter; J G Guccion
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

6.  The release of intact oligosaccharides from specific glycoproteins by endo-beta-N-acetylglucosaminidase H.

Authors:  A L Tarentino; T H Plummer; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

7.  Identification of T cell lymphoma tumor antigens on human T cell lines.

Authors:  J Kaplan; J Tilton; W D Peterson
Journal:  Am J Hematol       Date:  1976       Impact factor: 10.047

8.  Methods in laboratory investigation. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human t cell leukemia-lymphoma virus.

Authors:  C Saxinger; R C Gallo
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

9.  Antibodies to human T cell leukaemia virus-associated membrane antigens in haemophiliacs: evidence for infection before 1980.

Authors:  B L Evatt; S F Stein; D P Francis; D N Lawrence; M F McLane; J S McDougal; T H Lee; T J Spira; C Cabradilla; J I Mullens; M Essex
Journal:  Lancet       Date:  1983-09-24       Impact factor: 79.321

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  36 in total

1.  Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus.

Authors:  L D Papsidero; R P Dittmer; L Vaickus; B J Poiesz
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

2.  HTLV-I antibody studies in villagers in East Sepik Province, Papua New Guinea.

Authors:  R C Sanders; A Levin; G Anian; I Webber; H Lee; P Swanson; A Diwan; R Desowitz; W A Blattner; M P Alpers
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.

Authors:  Min Li; Patrick L Green
Journal:  J Virol Methods       Date:  2007-03-06       Impact factor: 2.014

4.  Mutational analysis of conserved N-linked glycosylation sites of human immunodeficiency virus type 1 gp41.

Authors:  W R Lee; X F Yu; W J Syu; M Essex; T H Lee
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

Review 5.  The epidemiology of HTLV-I infection.

Authors:  N Mueller
Journal:  Cancer Causes Control       Date:  1991-01       Impact factor: 2.506

6.  Peripheral T-lymphocyte activation by human T-cell leukemia virus type I interferes with the CD2 but not with the CD3/TCR pathway.

Authors:  M D Dodon; A Bernard; L Gazzolo
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I.

Authors:  S Matsushita; M Robert-Guroff; J Trepel; J Cossman; H Mitsuya; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

8.  Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.

Authors:  L Delamarre; C Pique; D Pham; T Tursz; M C Dokhélar
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme.

Authors:  E F Terwilliger; B Godin; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Hematological indices in a cohort of HTLV-I/II and HIV-1 infected intravenous drug users in New York City.

Authors:  L S Brown; A Chu; H Lee; J P Allain
Journal:  J Natl Med Assoc       Date:  1991-08       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.